PatientsLikeMe

PatientsLikeMe names Greg Ploussios SVP and General Counsel

Thursday, August 3, 2017

PatientsLikeMe has named Greg Ploussios to the newly-created role of Senior Vice President and General Counsel. Prior to joining PatientsLikeMe, Ploussios served as the company’s outside counsel for over a decade, advising and negotiating PatientsLikeMe’s licensing, collaboration and commercial agreements and representing the company in equity financing, mergers and acquisitions, and other corporate matters, including its recent financing and partnership with iCarbonX.

[Read More]

PatientsLikeMe forms new senior leadership team with personalized health focus

Monday, May 22, 2017

PatientsLikeMe forms a new senior leadership team comprised of existing executives and new leaders. The team includes: Executive Vice President of Marketing, Technology and Operations Michael Evers, who joined PatientsLikeMe in 2012; George Parker, executive vice president of Human Resources since 2016; newly-appointed executive vice president of Research and Development (R&D) Jonathan White; and Monique Levy, who joined PatientsLikeMe in 2016 and has been promoted to executive vice president, Business Solutions and Partnerships. The team reports to Co-Founder and President Ben Heywood. Co-founder Jamie Heywood remains as PatientsLikeMe’s chairman and is focused on driving the company’s vision.

[Read More]

Envisioning the site of the future

Monday, May 1, 2017

The drug development world has been notoriously slow to adopt change, but industry leaders and visionaries expect the clinical research enterprise to change dramatically.
Integration of healthcare data, the power of data and analytics, a rapid move toward more targeted therapies and customized treatments, along with the desire for a lower cost R&D model are among the forces driving transformation in the way the research environment will function in the future.

[Read More]

Collaborative definition of patient centricity by AstraZeneca, patients and carers

Friday, March 31, 2017

AstraZeneca has announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry. The definition was co-developed with patients and caregivers using research led by AstraZeneca and patient community advocates to ensure a deep understanding of patient needs and values. Ten associated patient-centric principles were also identified and published in BMJ Innovations to provide the pharmaceutical industry with a consistent reference point to sustain meaningful and mutually beneficial engagement with patients. Wider testing of these outputs among U.S. and European patient communities confirmed their validity.

[Read More]

PatientsLikeMe names Marni Hall senior vice president

Monday, July 11, 2016

PatientsLikeMe has appointed Marni Hall, Ph.D., MPH, as its new senior vice president of Research and Policy. A distinguished research scientist and public policy expert, Hall will develop and direct the strategies and teams focused on expanding the role of real-world evidence in precision medicine, and in the research agendas of PatientsLikeMe and its customers.

[Read More]

Pharma industry improves its tarnished reputation

Monday, June 15, 2015

The reputation of the pharmaceutical industry—historically not much better than that of the oil or tobacco industries—has stabilized in recent years. And public views about clinical research have improved significantly. Yet overall, the level of trust in pharmaceutical companies remains low.

[Read More]